Anti-LAG3 (clone Ab9Q) SynExpress E1-Cy2-I17-P Modified CD8+ T cells

CAT#: ITS-1224-CR1989
Clone: Ab9Q
Host: Humanized
Cell Source: Modified CD8+ T cells
Species Reactivity: Human
Connector Fragments: EF1α-Cy2-IL-17-PstI
Carrier Type: pCDNA
Description
This product utilizes Modified CD8+ T cells that have been engineered with our proprietary GeneCircuit technology to specifically target LAG3 (clone Ab9Q). We employs the pCDNA (EF1α-Cy2-IL-17-PstI) vector components and the SynExpress system of the Single base pair Knockout/Delayed feedback for a robust and sustained response against cancers.
Host
Humanized
Target
LAG3
Clone
Ab9Q
Species Reactivity
Human
Cell Source
Modified CD8+ T cells
Sensor Gene
Cy2
Promoter
EF1α
Effector Gene
IL-17
Insertion Sites
PstI
Gene Modification
Knockout
Modification Domain
Single base pair
Carrier Type
pCDNA
Transformation Accuracy
0.91
Cell Culture
3D Culture
Target
LAG3
Alternative Names
LAG3; CD223; lymphocyte activating 3
Gene ID
P18627(Human)
UniProt ID
3902(Human)
Format
Lyophilized/Liquid
Shipping
All cell products are transported using dry ice, or specialized refrigerated containers to ensure that their temperature remains within an appropriate range. For cell products that are particularly sensitive to temperature, transportation must be carried out in liquid nitrogen tanks to ensure the quality and viability of the products.
Handling Advice
Handle cells in a sterile environment to prevent contamination. Use aseptic techniques when transferring to new media or containers. Follow biosafety regulations for disposing of cell waste.
Storage
Keep cell products in the designated temperature range (usually liquid nitrogen or -80°C) to maintain viability.
For Research Use Only | Not For Clinical Use
Online Inquiry